Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Press release

Redeye: Arise - Positioned for high activity in H2 2025

Arise

Arise presented a quarter with many moving parts and one-off effects that blurred the underlying financial performance. In addition, Q1 2025 faced tough comparable numbers. Despite all this, we think that the underlying Q1 numbers were more or less in line with our estimates, and we think that the share price reaction since the report's publication (-7%) is rather unwarranted. We think this could present an attractive entry-point for the long-term investor (or even the short-term investor) given that H2 2025 should generate at least two project transactions – which we consider strong catalysts. We update our estimates and fair value range following the report.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments


Arise - Positioned for high activity in H2 2025

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.